Small-molecule inhibitors of lysine methyltransferases SMYD2 and SMYD3: current trends

Area of Science:

• Biochemistry
• Epigenetics
• Medicinal Chemistry

Background:

• Lysine methyltransferases SMYD2 and SMYD3 regulate cell differentiation and function.
• Their overexpression is linked to cancer development, making them potential therapeutic targets.
• Understanding their precise roles in tumors requires selective chemical probes.

Purpose of the Study:

• To systematically review chemical probes targeting SMYD2 and SMYD3.
• To highlight structural features essential for potent inhibition.
• To analyze inhibition mechanisms and efficacy in biological models.

Main Methods:

• Literature review of chemical probes targeting SMYD2 and SMYD3.
• Analysis of structure-activity relationships for inhibitory compounds.
• Evaluation of inhibition modes and cellular/in vivo efficacy.

Main Results:

• Overview of diverse chemical scaffolds developed as SMYD2/SMYD3 inhibitors.
• Identification of key structural determinants for high inhibitory activity.
• Summary of findings on inhibition mechanisms and demonstrated efficacy.

Conclusions:

• Selective small-molecule inhibitors are vital tools for validating SMYD2 and SMYD3 as cancer targets.
• Further development of these probes will advance targeted cancer therapy strategies.
• This review provides a foundation for future drug discovery efforts.